Commitment COM-267
Post-approval commitment for TGA-2023-0067. Category: Risk Management. Priority: high.
Commitment ID
COM-267
Application
Authority
Therapeutic Goods Administration
Category
Risk Management
Priority
high
Status
In Progress
Due Date
2025-07-26
Completed At
—
Owner
Tomoko Ikeda
Created
2023-06-16
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.